Shareholders meeting

AJOONI BIOTECH LIMITED Regd. Office: D-118, Industrial Area, Phase VII, Mohali-160055 (Pb.) Corp Office: H.No 1769, Phase 3B2, Mohali-160059 Phone: 0172-5020758-69 Website: www.ajoonibiotech.com E-mail: ajooni.biotech@gmail.com / info@ajoonibiotech.com CIN: L85190PB2010PLC040162 July 01, 2026 National Stock Exchange of India Ltd Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai - 400051 Dear Sir / Madam, SYMBOL: AJOONI ISIN: INE820Y01021 Subject: Intimation of Notice of the 16th Annual General Meeting for the financial year ended 31st March, 2026 through Video Conferencing Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Notice along with Explanatory Statement of the 16th Annual General Meeting of the Company for the financial year ended 31st March, 2026 to be held on Wednesday, 29th day of July 2026, through Video Conferencing/ Other Audio Visual Means in compliance with the circulars issued by the Ministry of Corporate Affairs (‘MCA’), Government of India and Securities and Exchange Board of India (‘SEBI’) and all other applicable laws. Kindly take the same on your records. Thanking You, Yours Truly, For, AJOONI BIOTECH LIMITED Swati Vijan Company Secretary FCS13627 Enclo: As Above Works: G.T. Road, Khanna- 141401 (Punjab) INDIA AJOONI BIOTECH LIMITED Registered office: D-118, Industrial Area, Phase VII, Mohali, Punjab-160059 Corporate Office : House NO. 1769, Phase 3B2, Mohali, Punjab-160055 CIN: L85190PB2010PLC040162; E-mail: ajooni118@gmail.com/cs@ajoonibiotech.com/ info@ajoonibiotech.com , Website: https://ajoonibiotech.com NOTICE OF 16TH ANNUAL GENERAL MEETING NOTICE IS HEREBY GIVEN THAT THE 16TH ANNUAL GENERAL MEETING (‘AGM’) OF THE SHAREHOLDERS OF AJOONI BIOTECH LIMITED (‘THE COMPANY’) WILL BE HELD ON WEDNESDAY, 29TH DAY OF JULY, 2026, AT 11.00 A.M. THROUGH VIDEO CONFERENCING (‘VC’)/ OTHER AUDIO-VISUAL MEANS (OAVM) FACILITY TO TRANSACT THE FOLLOWING BUSINESS: ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended 31st March, 2026, together with the Reports of the Board of Directors and Auditors thereon. 2. To re-appoint a Director in place of Mr. Gursimran Singh (DIN: 02209675) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re- appointment. SPECIAL BUSINESS: 3. INCREASE IN AUTHORISED SHARE CAPITAL To consider and if thought fit, to pass with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 61 and 64 and other applicable provisions, if any, of the Companies Act, 2013 read with the Companies (Share Capital & Debentures) Rules, 2014 (including any statutory modification(s) or re-enactment thereof for the time being in force), the consent of the members of the Company be and is hereby accorded for increasing the Authorized Share Capital of the Company from existing Rs. 50,00,00,000 (Rupees Fifty Crores Only) divided into 25,00,00,000 (Twenty Five Crores) Equity Shares having face value of Rs. 2/- each (Rupees Two Only) to Rs. 70,00,00,000/- (Rupees Seventy Crores) divided into 35,00,00,000 (Thirty Five Crores) Equity Shares of having face value of Rs. 2/- (Rupees Two Only) by creating additional 10,00,00,000 (Ten Crores) Equity Shares of Rs. 2/- each amounting Rs. 20,00,00,000 (Rupees Twenty Crores Only) ranking pari passu with the existing Equity Shares of the Company. RESOLVED FURTHER THAT pursuant to the provisions of Section 13 read with Section 61 and 64 and other applicable provisions, if any, of the Companies Act, 2013 (including any statutory modification(s) or re-enactment thereof for the time being in force) and subject to the approval of Shareholders of the Company, the existing clause V of the Memorandum of Association of the Company be substituted as follows: V. The Authorised Share Capital of the Company is Rs. 70,00,00,000/- (Rupees Seventy Crores Only) divided into 35,00,00,000 (Thirty Five Crores) Equity Shares of having face value of Rs. 2/- (Rupees Two Only) each. RESOLVED FURTHER THAT any of the Directors the Company, be and is hereby authorized to sign and file all necessary documents and forms as may be deemed necessary in this connection with the Registrar of Companies and to do all such acts, deeds and things as may be necessary and expedient for giving effect to this resolution.” 4. ISSUANCE OF EQUITY SHARES ON A PREFERENTIAL BASIS.: To consider and if thought fit, to pass with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 23, 42, 62(1)(c) and other applicable provisions, if any, of the Companies Act, 2013 (the “Act”), Companies (Prospectus and Allotment of Securities) Rules, 2014, Companies (Share Capital and Debentures) Rules, 2014, (including any amendment(s), modification(s) or re-enactment thereof), for the time being in force and in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “ICDR Regulations”) and the Securities and Exchange Board of India (Substantial Acquisitions and Takeovers) Regulations, 2011, as amended (the “Takeover Regulations”) and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “LODR Regulations”) and any other rules, regulations, guidelines, notifications, circulars and clarifications issued there under from time to time by the Government of India, the Reserve Bank of India, the Securities and Exchange Board of India and NSE, the stock exchange where the shares of the company are listed (Stock Exchange) and any other guidelines and clarifications issued by any other appropriate authority, from time to time, to the extent applicable including the enabling provisions of the Memorandum and Articles of Association of the Company, and subject to such approvals, consents, permissions and sanctions as may be necessary or required and subject to such conditions as may be imposed or prescribed while granting such approvals, consents, permissions and sanctions, the consent and approval of the Members of the Company be and is hereby accorded to the Board to issue, offer and allot from time to time in one or more tranches:- Upto 90,00,000 (Ninety Lacs) Equity Shares of face value of Rs. 2/- each, at a price of Rs. 4.30/- (Rupees Four and Thirty Paise Only) (Issue Price) per Equity Share (including a premium of Rs. 2.30/- per Equity Share), aggregating to Rs. 3,87,00,000/- (Rupees Three Crores Eighty Seven Lacs Only) to Promoter as follows: Details of the Proposed Allottee No. of Equity Proposed Sl. Name of the Proposed Current Status Shares to be Status / No. Allottee / Category allotted Category Healthy Biosciences 90,00,000 Promoter Promoter Limited Total 90,00,000 on such other terms and conditions as set out in the Statement annexed to the Notice convening this meeting, as the Board may in its absolute discretion decide, subject to applicable laws and regulations, including the provisions of Chapter V of the ICDR Regulations and the Act. RESOLVED FURTHER THAT in terms of the provisions of Chapter V of the ICDR Regulations, the relevant date for determining the minimum issue price for the Preferential Allotment of the Equity Shares is the June 29, 2026, being the date 30 days prior to the date of this Annual General Meeting and the minimum issue price has been determined accordingly in terms of the applicable provisions of the ICDR Regulations. RESOLVED FURTHER THAT without prejudice to the generality of the above, the issue of Equity Shares shall be sub [Showing first 8,000 characters — download PDF for full document]